Molina Healthcare, Inc. (MOH)
What changed in recent filings
- Institutions — 2 added · 3 reduced13F · as of end of 2026 Q2
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Molina Healthcare, Inc. recent earnings releases
Based on SEC filings. The release date is the day the earnings filing (8-K) was accepted; for quarters where that filing was not found, the periodic report filing date is shown.
- 26Q2Released Jul 22, 2026Revenue -4.8% YoY · EPS $1.19Released after the close: Jul 22 close → Jul 23 close, the stock moved -9.7% · over the same window, market -1.2% · sector +0.5%
- 26Q1Released Apr 22, 2026Revenue -3.1% YoY · EPS $0.27Released after the close: Apr 22 close → Apr 23 close, the stock moved +14.2% · over the same window, market -0.4% · sector -0.2%
- 25Q4Released Feb 5, 2026Revenue +8.3% YoY · EPS $-2.87Released after the close: Feb 5 close → Feb 6 close, the stock moved -25.5% · over the same window, market +1.9% · sector +1.8%
- 25Q3Released Oct 22, 2025Revenue +11.0% YoY · EPS $1.51Released after the close: Oct 22 close → Oct 23 close, the stock moved -17.5% · over the same window, market +0.6% · sector -0.3%
Institutions holding Molina Healthcare, Inc.
How many of the institutions we track reported holding this stock, quarter by quarter.
2019 Q1: 1 → 2026 Q2: 6 institutions
Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.
Which institutions hold Molina Healthcare, Inc.
Institutions we track that reported holding this stock in their most recent 13F.
- Capital World Investors0.07% of portfolio · held as of 2020 Q3 or earlier
- Bridgewater Associates0.01% of portfolio · since 2022 Q4
- Tudor Investment Corp0.03% of portfolio · since 2024 Q4
- Harris Associates (Oakmark)0.29% of portfolio · since 2025 Q1
- Baupost Group2.68% of portfolio · since 2025 Q4
- Blackstoneunder 0.01% of portfolio · since 2026 Q1
Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.
Q2 2026 13F recap — stocks several institutions bought and sold together →Company overview
Molina Healthcare Inc. is a managed care company that provides health coverage and related services to low-income individuals and families through Medicaid, Medicare, and state insurance marketplace programs. The company focuses on government-sponsored healthcare, offering Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans. Its business is organized across Medicaid, Medicare, Marketplace, and Other segments, reflecting a model centered on administering public and subsidized health benefits. Molina Healthcare Inc. serves members across multiple U.S. states and plays a significant role in coordinating access to medical care, benefits administration, and healthcare network management. Founded in 1980 and headquartered in Long Beach, California, Molina Healthcare Inc. is a major participant in the U.S. managed healthcare market.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
Molina Healthcare, Inc. is classified under the Biotech & Health sector. See peers below.
Molina Healthcare, Inc. key financials
Based on SEC filings · as of Jun 30, 2026
Tap a metric name to see its meaning in the glossary.
Molina Healthcare, Inc. vs Biotech & Health sector benchmark
Median of 38 representative sector stocks · SEC filings · factual comparison (not advice)
A simple comparison to the sector benchmark. Higher or lower doesn’t mean good/bad or buy/sell.
ETFs holding Molina Healthcare, Inc.
Per SEC N-PORT · 2026-06-30 · by weight · factual
MOH on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — Valuation and growth compared with the Biotech & Health average
Peers · Biotech & Health
MOH FAQ
What is Molina Healthcare, Inc. (MOH)?
Molina Healthcare Inc. is a managed care company that provides health coverage and related services to low-income individuals and families through Medicaid, Medicare, and state insurance marketplace programs. The company focuses on government-sponsored healthcare, offering Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans. Its business is organized across Medicaid, Medicare, Marketplace, and Other segments, reflecting a model centered on administering public and subsidized health benefits. Molina Healthcare Inc. serves members across multiple U.S. states and plays a significant role in coordinating access to medical care, benefits administration, and healthcare network management. Founded in 1980 and headquartered in Long Beach, California, Molina Healthcare Inc. is a major participant in the U.S. managed healthcare market.
What sector is Molina Healthcare, Inc. in?
Molina Healthcare, Inc. is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
What are Molina Healthcare, Inc.'s key financials?
As of Jun 30, 2026 in SEC filings: Revenue growth (YoY) 2.6%, Operating margin 1.3%, Net margin -0.0%, ROE 11.6%, Debt-to-equity 0.90x. Definitions and interpretation are available on Stocklore.
Where can I analyze Molina Healthcare, Inc. (MOH) stock?
On Stocklore you can see MOH's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.